Drug Treatment Approved for Pediatric Patients with Multiple Sclerosis
May 14th 2018Officials with the FDA have approved fingolimod (Gilenya, Novartis) for the treatment of relapsing multiple sclerosis (MS) in pediatric patients aged 10 years and older, making it the first FDA-approved drug to treat MS in this population.
Survey: Nurse Practitioner Workforce Sees Substantial Growth
March 19th 2018The number of nurse practitioners has more than doubled over the past decade, reinforcing that the NP workforce is growing at an accelerated rate, according to new data released by the American Association of Nurse Practitioners.
Is Obesity Linked to More Severe Acute Respiratory Illnesses?
March 7th 2018Although obesity has been considered a risk factor for severe acute respiratory illness, including more severe cases of the flu, a recently-published study found that weight may not be associated with increased illness severity.